LS-P-MAST

LS-P-MAST: A Phase 1/2, Open Label, First-In-Human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Tumor Activity of SAR445877 Administered as Monotherapy in Adults with Advanced Solid Tumors

Status:

OPEN TO ACCRUAL

Trial Type:

Breast, Endocrine Neuroendocrine, Eye, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Leukemia, Lymphoma, Multiple Myeloma, Musculoskeletal, Other Hematology, Skin, Thoracic, Unknown Primary

Age Group:

Adults

Phase:

I/II

NCT Number:

Contact:

Almhanna, Khaldoun

kalmhanna@BrownHealth.org